Home / Health / RA Treatment Delays Disease for Years
RA Treatment Delays Disease for Years
21 Jan
Summary
- Treatment with abatacept delays rheumatoid arthritis onset.
- Benefits of abatacept treatment extended for years.
- Study shows delayed disease onset up to four years.

Researchers have discovered that a specific treatment can effectively delay the onset of rheumatoid arthritis (RA) in individuals identified as high risk for the disease.
The study, led by King's College London, assessed the longer-term impact of abatacept, a drug designed to target the root causes of inflammation associated with RA.
Findings indicate that the positive effects of abatacept persisted well past the initial one-year treatment course. Participants receiving the drug experienced a significantly longer period before developing RA compared to those given a placebo, with disease onset delayed by up to four years after treatment concluded.
While not a permanent cure, the research suggests abatacept can postpone the disease's development. Professor Andrew Cope highlighted that early intervention offers lasting benefits, is safe, and can substantially improve patients' quality of life by reducing the duration of symptoms and complications.


